What is Anatomic Pathology Market?
Anatomic Pathology is the process of the observation of the organs and tissues to help in knowing the reasons and effects of particular diseases. Anatomic pathology involves the diagnosis of various types of cancer, infectious diseases, and medical conditions through the examination of cells and tissue samples, which are collected from patients through biopsy. The market is witnessing high growth due to an increasing prevalence of chronic diseases and increasing healthcare expenditure. The anatomical pathologist’s conclusions are essential to medical diagnosis, patient management, and research.
The market study is being classified by Type (Instruments (Tissue Processors, Microtome, Cryostats, Others), Consumables (Reagents(Stains & Dyes,Fixatives,Others), Antibodies) and Histopathology), by Application (Diseases Diagnosis, Drug Discovery & Development and Other Applications) and major geographies with country level break-up.
F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (United States), Thermo Fisher Scientific Inc. (United States), Hologic, Inc. (United States), Koninklijke Philips N.V.( Netherlands), Agilent Technologies (United States), Becton, Dickinson, and Company (United States), Sakura Finetek (Japan), Merck KGaA (Germany), Bio SB (United States), Diapath S.p.A. (Italy) and BioGenex Laboratories (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Oxford Cancer Biomarkers Ltd. (United Kingdom), Enzo Biochem Inc. (United States) and Epic Sciences (United States).
The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Anatomic Pathology market throughout the predicted period.
Analyst at AMA have segmented the market study of Global Anatomic Pathology market by Type, Application and Region.
On the basis of geography, the market of Anatomic Pathology has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Rising Prevalence of Chronic Diseases
- Growing Demand for Personalized Medicine
- Emerging Technology in Medical Device
- Reagent Rental Agreements
- High Degree of Consolidation in this Industry
- Stringent Government Regulations Pertaining to Anatomic Pathology
- High-quality Infrastructure for Hospitals and Clinical Laboratorie
- Increasing Number of Clinical Trials Pertaining to Cancer Drugs
- Lack of Skilled Professionals
Market Leaders and some development strategies
In Jan 2018, Cancer informatics and digital pathology workflow solution provider Inspirata®, Inc. announced today that it has acquired Pittsburgh, PA-based Omnyx from GE Healthcare.
In Oct 2018, Henry Ford Health System Pathology and Laboratory Medicine announced a research and development partnership with Sakura Finetek USA to increase the automation level of its core anatomic pathology laboratories, thereby increasing the quality of results while reducing turnaround time, minimizing errors, and lessening the need for human intervention.
Key Target AudienceNew Entrants/Investors, Analysts and Strategic Business Planners, Anatomic Pathology Instrument Manufacturer, Anatomic Pathology Instrument Suppliers/Distributors, Raw Material Suppliers, Pathology Service Provider, Government Regulatory and Research Organizations and End-Use Industry
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase